The dietary supplements segment remains the backbone of the global pyruvate market, projected to hold a 40.0% revenue share ...
A 17-year-old girl who has had more than 100 blood transfusions has told how the donations helped her to "lead a normal life" ...
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: ...
Sanofi (SNY) stock and Insmed (INSM) stock are in focus as new treatments from the companies win backing from an expert panel ...
Backed by GV and Arch Venture Partners, Pelage Pharmaceuticals is advancing a first-of-its-kind topical gel designed to ...
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...
Introduction Mitochondrial dysfunction and disrupted cerebral energy metabolism have been increasingly linked to the ...
Prescription Drug User Fee Act (PDUFA) target action date is March 28, 2026All primary and secondary endpoints were met, and ...
The message will be seen by millions of people each year who register for a new driving license, in the hopes to encourage ...
ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Sept. 8, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug ...
A Michigan woman has shared dramatic footage of the moment her uterus began to rupture. Holly Cieslinski, from Grand Rapids, shared footage to TikTok @hollycski of the moment she lent over her ...
Pharmaceutical Technology on MSN
SFDA approves Agios Pharma’s Pyrukynd for thalassemia
Agios entered a distribution agreement with NewBridge in 2024, focusing on regulatory filings and commercialisation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback